S-2 Methanandamide Catalog No.:M22751-C SAR629 inhibits rodent monoglyceride lipase

SAR629 inhibits rodent monoglyceride lipase (MGL) activity at subnanomolar potencies (IC50 values of 1

5-trimethyl-6-oxo-4

Smiles: NC1=NC(OCC2=CC(Br)=CS2)=C2NC=NC2=N1

5-d]pyrimidin-7-yl}sulfanyl)-1

Roburic acid

S-2 Methanandamide Catalog No.:M22751-C SAR629 inhibits rodent monoglyceride lipaseS 2 methanandamide is a CB1 receptor ligand. The cannabinoid receptor type 1 (CB1), is a G protein coupled cannabinoid receptor located mainly in the central and peripheral nervous system. CB1 is also expressed in several cells relating to metabolism, such as muscle cells, fat cells, liver cells, and the digestive tract. The CB1 receptor has been involved in the maintenance of homeostasis in health and disease, preventing the development of excessive